The Global BreastLesion Localization Methods Market, By Technique (Wire Guided Localization,Radio Guided Occult Lesion Localization, Radioactive Seed Localization,Magnetic Tracers, and Ultrasound Guided Surgery), End User (Hospitals,Specialized Clinics, Research Institutes, and Ambulatory Surgical Centers), andby Region (North America, Latin America, Europe, Asia Pacific, Middle East, andAfrica), was valued at US$ 530.2 million in 2018 and is projected to exhibit aCAGR of 10.7% over the forecast period (2019 – 2027).
Increasing incidence and prevalenceof breast cancer is expected to drive growth of the global breast lesionlocalization methods market
According to WHO report publishedin 2018, breast cancer is the most frequent cancer among women, impacting 2.1million women each year though the world. It is estimated that around 627,000women died due to breast cancer, which is around 15% of all cancer deaths amongwomen globally. Moreover, increasing government initiatives to increaseawareness about breast cancer in developed and emerging regions is alsoexpected to propel growth of the breast lesion localization methods marketduring the forecast period. For instance, according to The Pink Initiative andBreast Cancer Statistics in India, in 2014, a significantly large population ofpatients below the age of 50 years suffered from breast cancer.
Around 16% were between the ageof 20 and 40, and 28% were between the age of 40 and 50. Increasing patientpopulation in such regions with high potential is expected to improve the timeto market of highly effective and advanced products. Furthermore, increasingnumber of mergers and acquisitions is also expected to drive growth of theglobal breast lesion localization methods market during the forecast period.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/104
For instance, in January 2019,IZI Medical Products acquired select soft tissue biopsy and breast localizationneedle assets from Cook Medical. The acquisition is expected to expand productportfolio of IZI Medical Products with addition of MReye Breast LocalizationCoil.
Browse 32 Market Data Tables and28 Figures spread through 175 Pages and in-depth TOC on ‘Breast LesionLocalization Methods Market, By Technique (Wire Guided Localization, RadioGuided Occult Lesion Localization, Radioactive Seed Localization, MagneticTracers, and Ultrasound Guided Surgery), End User (Hospitals, SpecializedClinics, Research Institutes, and Ambulatory Surgical Centers), and by Region(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -Global Forecast to 2027”
Increasing incidence andprevalence of breast cancer has led to rising demand for breast cancer lesionlocalization products. Therefore, manufactures are expanding their productportfolio and geographical reach by increasing product launches and approvals.For instance, in March 2019, Hologic received CE certification for itsLOCalizer wireless radiofrequency identification breast lesion localizationsystem. The system is designed to replace wire-guided breast lesion localizationtechnique. Key players in the market are focused on adopting strategies such aspartnerships and acquisitions to expand their product portfolio andgeographical presence in the global breast lesion localization methods market.For instance, in July 2018, Hologic Inc. announced that it completed theacquisition of Faxitron Bioptics, a privately held leader in digital specimenradiography, breast lesion localization, and sentinel lymph node biopsy.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/breast-lesion-localization-methods-market-104
Key Takeaways of the BreastLesion Localization Methods Market:
The global breast lesionlocalization methods market is expected to exhibit a CAGR of 10.7% over theforecast period, owing to increasing incidence of breast cancer, increasinggovernment initiative to promote awareness, and increasing product launches. Forinstance, according to the American Cancer Society reports published in 2019,around 268,600 new cases of invasive breast cancer will be diagnosed in womenduring 2019 and the incidence rate increased by 0.4% per year.
Among technique, the wire guidedlocalization segment exhibited highest CAGR in the global breast lesionlocalization methods market in 2018. This growth was due to the earlyestablishment and higher adoption of this technique among end users.
Among end user, the hospitalsegment held dominant position in the global breast lesion localization methodsmarket in 2017, owing to favorable reimbursement policies. According toAmerican Cancer Society, one time screening mammogram every 12 months iscovered fully under Medicare for all women aged 40 years and older. Also, itpays for clinical breast exam (CBE) in every 24 months once, for women withaverage risk of breast cancer. This in turn is expected to increase rate ofbreast cancer screening and in turn drive growth of the breast lesion localizationmethods market in the near future.
Key players operating in theglobal breast lesion localization methods market include Cook Medical Inc.,Argon Medical Devices, Inc., Becton, Dickinson and Company (C. R. Bard),SOMATEX Medical Technologies GmbH, Sterylab Medical, Biopsybell Srl, HologicInc., and Tsunami S.r.l.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/104
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200 Seattle,WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
